SCHEMBL31514563

SCHEMBL31514563

CN1CCN(c2ccc(-c3ccc4c(Nc5c(F)cccc5F)ncnc4c3)cn2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.51
▸ AURKB Q96GD4 10/20 0.45
▸ RAF1 P04049 1/20 0.45
▸ BRAF P15056 1/20 0.45
▸ KIT P10721 2/20 0.45
▸ FLT3 P36888 2/20 0.45
▸ TDO2 P48775 1/20 0.45
▸ AURKA O14965 1/20 0.45
▸ MAP4K4 O95819 1/20 0.44
▸ ATM Q13315 2/20 0.42
▸ MELK Q14680 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514586 0.95 EGFR (0.48) EGFRAURKBRAF1BRAFKIT
SCHEMBL31514594 0.89 AURKB (0.49) EGFRAURKBRAF1BRAFKIT
SCHEMBL31514623 0.88 CNR2 (0.52) EGFRAURKBRAF1BRAFKIT
SCHEMBL31514564 0.85 TDO2 (0.48) EGFRAURKBKITFLT3TDO2
SCHEMBL31514556 0.85 FGFR1 (0.49) EGFRAURKBRAF1BRAFKIT
SCHEMBL31514621 0.85 EGFR (0.50) EGFRAURKBKITFLT3TDO2
SCHEMBL31514608 0.82 DGAT1 (0.50) EGFRAURKBBRAFTDO2MAP4K4
SCHEMBL31514561 0.82 DGAT1 (0.50) EGFRAURKBTDO2MAP4K4
SCHEMBL31514603 0.82 EGFR (0.47) EGFRAURKBBRAFKITFLT3
SCHEMBL31514585 0.80 CD38 (0.48) EGFRAURKBRAF1BRAFKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912429-A Quinazoline compound with anti-inflammatory activity or pharmaceutically acceptable salt thereof, pharmaceutical composition and application thereof 安徽医科大学 2025-05-02 — — CN disclosed
Send feedback